Incyte Corp (INCY)
50.67
-1.07
(-2.07%)
USD |
NASDAQ |
Apr 25, 11:18
Incyte Cash from Financing (TTM): -20.03M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -20.03M |
September 30, 2023 | -22.86M |
June 30, 2023 | 0.086M |
March 31, 2023 | 3.119M |
December 31, 2022 | -0.794M |
September 30, 2022 | 10.69M |
June 30, 2022 | 5.659M |
March 31, 2022 | -6.563M |
December 31, 2021 | 6.176M |
September 30, 2021 | 9.043M |
June 30, 2021 | 29.32M |
March 31, 2021 | 82.04M |
December 31, 2020 | 71.71M |
September 30, 2020 | 89.16M |
June 30, 2020 | 91.12M |
March 31, 2020 | 43.72M |
December 31, 2019 | 45.71M |
September 30, 2019 | 20.45M |
June 30, 2019 | 20.00M |
March 31, 2019 | 16.55M |
December 31, 2018 | 14.66M |
September 30, 2018 | 14.32M |
June 30, 2018 | 665.88M |
March 31, 2018 | 670.84M |
December 31, 2017 | 690.21M |
Date | Value |
---|---|
September 30, 2017 | 686.34M |
June 30, 2017 | 39.47M |
March 31, 2017 | 56.70M |
December 31, 2016 | 44.62M |
September 30, 2016 | 52.06M |
June 30, 2016 | 58.54M |
March 31, 2016 | 61.94M |
December 31, 2015 | 84.74M |
September 30, 2015 | 106.56M |
June 30, 2015 | 99.59M |
March 31, 2015 | 81.21M |
December 31, 2014 | 93.06M |
September 30, 2014 | 294.89M |
June 30, 2014 | 315.12M |
March 31, 2014 | 302.35M |
December 31, 2013 | 275.59M |
September 30, 2013 | 52.14M |
June 30, 2013 | 34.18M |
March 31, 2013 | 52.07M |
December 31, 2012 | 47.71M |
September 30, 2012 | 41.98M |
June 30, 2012 | 34.14M |
March 31, 2012 | 28.76M |
December 31, 2011 | 19.47M |
September 30, 2011 | 21.26M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-22.86M
Minimum
Sep 2023
91.12M
Maximum
Jun 2020
25.15M
Average
10.69M
Median
Sep 2022
Cash from Financing (TTM) Benchmarks
Novartis AG | -14.28B |
MorphoSys AG | -- |
Illumina Inc | -1.21B |
Biogen Inc | 149.30M |
Pfizer Inc | 26.07B |